UMDNJ-Robert Wood Johnson — New Brunswick, New Jersey

UMDNJ-Robert Wood Johnson is a clinical research site located in New Brunswick, New Jersey, United States.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

UMDNJ-Robert Wood Johnson has participated in 2 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2, Renal Insufficiency.

Sponsors: Novartis.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UMDNJ-Robert Wood Johnson?

UMDNJ-Robert Wood Johnson has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UMDNJ-Robert Wood Johnson conducted?

UMDNJ-Robert Wood Johnson has 2 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Renal Insufficiency.

Is UMDNJ-Robert Wood Johnson accredited by Crixeo Health?

UMDNJ-Robert Wood Johnson has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UMDNJ-Robert Wood Johnson?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.